ECM
CVS icon

ETrade Capital Management’s CVS Health CVS Stock Holding History

ETrade Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$6.37M Buy
109,002
+9,407
+9% +$585K 0.12% 87
2020
Q2 		$6.47M Buy
99,595
+18,214
+22% +$1.15M 0.14% 83
2020
Q1 		$4.83M Sell
81,381
-13,669
-14% -$912K 0.12% 89
2019
Q4 		$7.06M Sell
95,050
-2,344
-2% -$165K 0.16% 72
2019
Q3 		$6.14M Sell
97,394
-37,394
-28% -$2.22M 0.15% 81
2019
Q2 		$7.34M Sell
134,788
-2,153
-2% -$116K 0.2% 49
2019
Q1 		$7.38M Buy
136,941
+43,097
+46% +$2.66M 0.21% 47
2018
Q4 		$6.15M Sell
93,844
-3,139
-3% -$234K 0.2% 48
2018
Q3 		$7.63M Buy
96,983
+8,502
+10% +$608K 0.22% 43
2018
Q2 		$5.69M Buy
88,481
+3,243
+4% +$214K 0.18% 54
2018
Q1 		$5.3M Buy
85,238
+5,671
+7% +$407K 0.17% 63
2017
Q4 		$5.77M Buy
79,567
+16,313
+26% +$1.19M 0.18% 57
2017
Q3 		$5.14M Buy
63,254
+7,601
+14% +$601K 0.18% 52
2017
Q2 		$4.48M Buy
55,653
+1,979
+4% +$156K 0.17% 57
2017
Q1 		$4.21M Buy
53,674
+1,172
+2% +$93.6K 0.17% 60
2016
Q4 		$4.14M Sell
52,502
-3,046
-5% -$246K 0.19% 55
2016
Q3 		$4.94M Buy
55,548
+2,411
+5% +$228K 0.24% 42
2016
Q2 		$5.09M Sell
53,137
-417
-0.8% -$41.6K 0.27% 34
2016
Q1 		$5.55M Sell
53,554
-1,207
-2% -$117K 0.32% 29
2015
Q4 		$5.35M Buy
54,761
+1,083
+2% +$106K 0.31% 30
2015
Q3 		$5.18M Buy
53,678
+685
+1% +$72K 0.32% 28
2015
Q2 		$5.56M Sell
52,993
-1,458
-3% -$149K 0.33% 28
2015
Q1 		$5.62M Sell
54,451
-4,523
-8% -$458K 0.33% 27
2014
Q4 		$5.68M Buy
58,974
+1,257
+2% +$111K 0.35% 23
2014
Q3 		$4.59M Buy
57,717
+940
+2% +$74.1K 0.3% 29
2014
Q2 		$4.28M Buy
56,777
+4,937
+10% +$373K 0.28% 34
2014
Q1 		$3.88M Sell
51,840
-1,007
-2% -$71.1K 0.28% 34
2013
Q4 		$3.78M Buy
52,847
+10,459
+25% +$672K 0.3% 32
2013
Q3 		$2.41M Buy
42,388
+9,113
+27% +$543K 0.22% 40
2013
Q2 		$1.9M Buy
+33,275
New +$1.93M 0.2% 39

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ETrade Capital Management's CVS Position: Q3 2020 in Review

ETrade Capital Management increased its CVS Health (CVS) stake by 9.4% in Q3 2020, buying an estimated $585K and bringing the position to 109,002 shares worth $6.37M. The position accounts for 0.12% of the portfolio, ranked #87.

ETrade Capital Management first reported a position in CVS in Q2 2013 and has held it in 30 quarters since. The position peaked at $7.63M in Q3 2018. 1,816 funds tracked by Wall St. Rank hold CVS as of Q3 2020.

  • ETrade Capital Management held 109,002 shares of CVS Health worth $6.37M as of Q3 2020.
  • ETrade Capital Management bought 9,407 CVS Health shares in Q3 2020, an estimated $585K.
  • CVS Health made up 0.12% of ETrade Capital Management's portfolio in Q3 2020, its #87 holding.
  • ETrade Capital Management first reported a position in CVS Health in Q2 2013 and has held it in 30 quarters since.
  • ETrade Capital Management's CVS Health position peaked at $7.63M in Q3 2018.
  • 1,816 funds tracked by Wall St. Rank held CVS Health as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.